Medtronic 2009 Annual Report Download - page 103

Download and view the complete annual report

Please find page 103 of the 2009 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 106

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106

99
Medtronic, Inc.
Investor Information
Annual Meeting
The annual meeting of Medtronic shareholders will take place
on Thursday, August 27, 2009, beginning at 10:30 a.m. (Central
Daylight Time) at Medtronic’s world headquarters, 710 Medtronic
Parkway, Minneapolis (Fridley), Minnesota.
Investor Information
Shareholders, securities analysts and investors seeking more
information about the Company can access the following
information via the Internet at www.medtronic.com:
• News releases describing significant Company events and sales
and earnings results for each quarter and the fiscal year.
• Form 10-K Annual, Form 10-Q Quarterly, and Forms 3, 4 and 5,
Reports to the Securities and Exchange Commission describing
Medtronic’s business and financial condition and insider trading.
The information above may also be obtained upon request from
the Medtronic Investor Relations Department, 710 Medtronic
Parkway, Minneapolis, Minnesota 55432, USA.
Stock Exchange Listing
New York Stock Exchange (symbol: MDT)
Price Range of Medtronic Stock
Fiscal Qtr. 1st Qtr. 2nd Qtr. 3rd Qtr. 4th Qtr.
2009 High $54.41 $56.55 $40.69 $34.56
2009 Low 46.98 37.81 28.67 24.38
2008 High 54.05 57.86 51.21 50.44
2008 Low 50.57 47.00 45.25 46.19
Prices are closing quotations. On June 29, 2009, there were
approximately 53,700 shareholders of record of the Company’s
common stock. The regular quarterly cash dividend was 18.75
cents per share for fiscal year 2009 and 12.50 cents per share for
fiscal year 2008.
Stock Transfer Agent and Registrar
Wells Fargo Shareowner ServicesSM acts as transfer agent and
registrar, dividend paying agent, and direct stock purchase plan
agent for Medtronic and maintains all shareholder records for the
Company. If you are a registered shareholder, you may access your
account information online at www.shareowneronline.com. If you
have questions regarding the Medtronic stock you own, stock
transfers, address or name changes, direct deposit of dividends,
lost dividend checks, lost stock certificates or duplicate mailings,
please contact Wells Fargo Shareowner ServicesSM by writing or
calling:
Wells Fargo Bank, N.A.
Shareowner Services
161 North Concord Exchange
South St. Paul, MN 55075 USA
Telephone: 888-648-8154 or 651-450-4064
Fax: 651-450-4033
www.wellsfargo.com/shareownerservices
Direct Stock Purchase Plan
Medtronic’s transfer agent, Wells Fargo Shareowner ServicesSM,
administers the direct stock purchase plan, which is called the
Shareowner Service Plus PlanSM. Features of this plan include direct
stock purchase and reinvestment of dividends to purchase whole
or fractional shares of Medtronic stock. All registered shareholders
and potential investors may participate.
To request information on the Shareowner Service Plus PlanSM, or
to enroll in the plan, contact Wells Fargo Shareowner ServicesSM at
888-648-8154 or 651-450-4064. You may also enroll on the Internet
by visiting www.shareowneronline.com and selecting “Invest in a
Direct Purchase Plan.”
Independent Registered Public Accounting Firm
PricewaterhouseCoopers LLP, Minneapolis, MN
Diversity
Medtronic is committed to creating and maintaining a workplace
that reflects the diversity of our customers, patients and the
communities we serve. Consistent with our Mission, Medtronic
“recognizes the personal worth of employees” and seeks to provide
a work environment where individual differences are valued and
respected and opportunities for growth and career success are
based on individual merit.
Officer Certifications
Medtronic has filed as exhibits to its Annual Report on Form 10-K
for the fiscal year ended April 24, 2009, the Chief Executive Officer
and Chief Financial Officer certifications required by Section 302 of
the Sarbanes-Oxley Act. The Company has also submitted the
required annual Chief Executive Officer certification to the New
York Stock Exchange.
For prescribing information for all of the products, visit
medtronic.com.
The following are registered and unregistered trademarks of
Medtronic, Inc. and its affiliated companies:
Activa, Adapta, Advantage, Advisa DR MRI, AneuRx AAAdvantage,
Aperius, Arctic Front, Attain Ability, Biolinx, CAPSTONE, CareLink,
CD HORIZON, CD HORIZON LEGACY, CD HORIZON LEGACY PEEK,
Concerto, Conexus, Consulta, CoreValve, CRESCENT, CryoCath,
DIAM, Driver, Legend EHS Stylus, Endeavor, Endeavor Resolute,
Endurant, EnRhythm MRI SureScan, Ensemble, Fusion, INFUSE,
InSync, IPC, IPD, InterStim, iPro, Kyphon, Marquis, MAST, Maximo,
Medtronic, Melody, MiniMed, Mosaic, Mosaic Ultra, MVP, NIM,
O-Arm, Optivol, Paradigm, Paradigm Veo, PEEK PREVAIL, PercLID,
Pillar, PRESTIGE, PrimeADVANCED, Restore, RestoreADVANCED,
RestoreULTRA, Reveal, S7, Secura, Sensia, Specify, Sprint Fidelis,
Sprint Quattro Secure S, StealthStation, Straightshot, Strata,
SureScan, SynchroMed II, Synergy, Talent, Valiant, Ventor, Versa,
VERTE-STACK, Vertex, Vertex Max, Vertex Select, Virtuoso, Vision 3D
and X-STOP.
InductOs is a trademark of Wyeth. PoleStar is a trademark of Odin
Medical Technologies, Inc.